Anxiety Disorders and Depression Treatment Market By Product Type (MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, SRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Anxiety Disorders and Depression Treatment Market Size was valued at USD 11.2 billion in 2022 and is poised to grow at a CAGR of 3.1% from 2023-29. Anxiety is a disorder that differs from normal feelings of nervousness or anxiousness. It involves excessive anxiety. Anxiety is a normal reaction to stress. For a patient with anxiety disorder, the anxiety does not lessen but can get worse over a period of time. As per the American Psychiatric Association, Anxiety disorders are the most common of mental disorders and affect nearly 30 percent of adults at some point in their lives. The feelings can interfere with daily activities. There are various kinds of anxiety disorders such as social anxiety disorder and panic disorder. 

Anxiety Disorders And Depression Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.10%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Anxiety Disorders and Depression Treatment Market Dynamics

Increase in the prevalence of anxiety disorder and depression is majorly driving the growth of the anxiety disorders and depression treatment market. According to the World Health Organization (WHO), in 2017, over 300 million people of all ages globally are suffering from depression, wherein 800,000 people die due to suicide, of which, anxiety disorders and depression are a prime cause. The rising demand for the antidepressants can be attributed to the growth of the market. Growing geriatric population along with mental disorders are adding fuel for the growth of the anxiety disorders and depression treatment market. However, the factors such as patent expiry of the drugs and adoption of the other treatment options such as herbal treatment are expected to hinder the growth of the market. The growing generic drugs are likely to restrain the growth of the anxiety disorders and depression treatment market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Anxiety Disorders And Depression Treatment Market Segmentation

By Product Type
  • MAOIs (Monoamine Oxidase inhibitors)
  • Atypical Antipsychotics
  • Benzodiazepines
  • Anticonvulsants
  • Beta-Blockers
  • SRIs (Selective Serotonin Reuptake Inhibitors)
  • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
  • TeCAs (Tetracyclic Antidepressants)
  • TCAs (Tricyclic Antidepressants)
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Others
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The anxiety disorders and depression treatment market size was valued at USD 11.2 billion in 2022

The anxiety disorders and depression treatment market key players are Eli Lilly and Company (U.S) Lundbeck A/S (Denmark) AstraZeneca (UK) Merck and Company, Inc. (U.S) Johnson and Johnson (U.S) Sanofi-Aventis (France) GlaxoSmithKline plc (UK) Pfizer, Inc. (U.S)

The anxiety disorders and depression treatment market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

  1. Executive Summary
  2. Global Anxiety Disorders and Depression Treatment Market Introduction
    • Global Anxiety Disorders and Depression Treatment Market Taxonomy
    • Global Anxiety Disorders and Depression Treatment Market Definitions
      • Product Type
      • Distribution Channel
  3. Global Anxiety Disorders and Depression Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Anxiety Disorders and Depression Treatment Market Dynamic Factors - Impact Analysis
    • Global Anxiety Disorders and Depression Treatment Market Competition Landscape
    • Epidemiology
  4. Global Anxiety Disorders and Depression Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  5. Global Anxiety Disorders and Depression Treatment Market, By Product Type, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • MAOIs (Monoamine Oxidase inhibitors)
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Atypical Antipsychotics
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Benzodiazepines
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anticonvulsants
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Beta-Blockers
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • SRIs (Selective Serotonin Reuptake Inhibitors)
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • TeCAs (Tetracyclic Antidepressants)
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • TCAs (Tricyclic Antidepressants)
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anxiety Disorders and Depression Treatment Market Forecast, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029
    • Hospital Pharmacies
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anxiety Disorders and Depression Treatment Market Forecast, By Region, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Anxiety Disorders and Depression Treatment Market - Opportunity Analysis Index, By Product Type, By Distribution Channel and Region, 2023 - 2029
  2. North America Anxiety Disorders and Depression Treatment MarketAnalysis,2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2016 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Anxiety Disorders and Depression Treatment Market - Opportunity Analysis Index, By Product Type, By Distribution Channel and Country, 2023 - 2029
    • North America Anxiety Disorders and Depression Treatment Market Dynamics Trends
  3. Europe Anxiety Disorders and Depression Treatment Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Anxiety Disorders and Depression Treatment Market - Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2023 - 2029
    • Europe Anxiety Disorders and Depression Treatment Market Dynamics Trends
  4. Asia-Pacific Anxiety Disorders and Depression Treatment Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Anxiety Disorders and Depression Treatment Market - Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2023 - 2029
    • Asia-Pacific Anxiety Disorders and Depression Treatment Market Dynamics Trends
  5. Latin America Anxiety Disorders and Depression Treatment Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Anxiety Disorders and Depression Treatment Market - Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2023 - 2029
    • Latin America Anxiety Disorders and Depression Treatment Market Dynamics Trends
  6. Middle East and Africa Anxiety Disorders and Depression Treatment Market Analysis, 2018 - 2022 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Anxiety Disorders and Depression Treatment Market - Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2023 - 2029
    • MEA Anxiety Disorders and Depression Treatment Market Dynamics Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Eli Lilly and Company (U.S)
      • Lundbeck A/S (Denmark)
      • AstraZeneca (UK)
      • Merck and Company, Inc. (U.S)
      • Johnson and Johnson (U.S)
      • Sanofi-Aventis (France)
      • GlaxoSmithKline plc (UK)
      • Pfizer, Inc. (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Eli Lilly and Company (U.S)
  • Lundbeck A/S (Denmark)
  • AstraZeneca (UK)
  • Merck and Company, Inc. (U.S)
  • Johnson and Johnson (U.S)
  • Sanofi-Aventis (France)
  • GlaxoSmithKline plc (UK)
  • Pfizer, Inc. (U.S)

Adjacent Markets